IpsiHand® is an FDA-cleared, non-invasive treatment of stroke. See if you qualify →

  • How It Works
  • Get IpsiHand
  • Resources
  • For Clinicians
Do I Qualify?
  • How It Works
  • Get IpsiHand
  • Resources
  • For Clinicians
  • How It Works
  • Get IpsiHand
  • Resources
  • For Clinicians
Do I Qualify?

Randomized Controlled Trial Demonstrated Positive Outcomes for FDA-Cleared Brain-Computer Interface IpsiHand® System in Chronic Stroke Rehabilitation

by KanduMarketing | Feb 12, 2026 | News

Post-market randomized study showed clinically meaningful improvement in upper extremity motor function compared to usual care VAN NUYS, CA – FEBRUARY 12, 2026 — Kandu, Inc., a healthcare technology company developing brain-computer interface (BCI)–enabled solutions...

Dr. Eric Leuthardt to Present Randomized Controlled Trial results on IpsiHand® at International Stroke Conference 2026

by KanduMarketing | Feb 3, 2026 | News

New Orleans, LA – FEBRUARY 3, 2026 — Kandu, Inc., a healthcare technology company developing brain-computer interface–enabled solutions for post-stroke recovery, today announced that Dr. Eric Leuthardt will present results of a randomized controlled trial studying the...

Kandu, Inc. Announces Appointment of Marshal Linder to Board of Directors and Strategic Growth Investment from K2 HealthVentures and Piper Sandler Merchant Bank

by KanduMarketing | Jan 12, 2026 | News

LOS ANGELES, CA – JANUARY 12, 2026 — Kandu, Inc., a healthcare technology company pioneering integrated stroke recovery solutions for post-stroke care, today announced the appointment of Marshal Linder to its Board of Directors. The company also announced the...

Recent Posts

  • Speech Therapy for Stroke Patients: Communication and Swallowing Recovery
  • Unlocking Language with Melodic Intonation Therapy: A Pathway to Speech Recovery in Stroke Survivors
  • Randomized Controlled Trial Demonstrated Positive Outcomes for FDA-Cleared Brain-Computer Interface IpsiHand® System in Chronic Stroke Rehabilitation
  • Dr. Eric Leuthardt to Present Randomized Controlled Trial results on IpsiHand® at International Stroke Conference 2026
  • Cognitive Rehabilitation Exercises for Memory and Attention After Stroke

Recent Comments

No comments to show.
About IpsiHand
  • How It Works
  • Get IpsiHand
  • Testimonials
  • Orthoses vs Therapeutic Devices
Resources
  • Resource Library
  • Insurance Coverage
  • Veterans Benefits
  • IpsiHand FAQ
    • FAQ Healthcare Professionals
  • Stroke Insights and Answers
  • News & Articles
  • For Clinicians
Company
  • About Neurolutions
  • Team
  • Careers
  • Contact Us
  • Important Safety Information
  • Notice of Non-Discrimination
  • Notice of Privacy Practices
  • Privacy Policy
  • FCOI Policy

.

  • Notice of Non-Discrimination
  • Notice of Privacy Practices
  • Privacy Policy
  • FCOI Policy
neurolutions logo
© Neurolutions, Inc. 2026. All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
neurolutions logo
© Neurolutions, Inc. 2026. All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Leo Petrossian

Leo Petrossian

Leo Petrossian is the current Chief Executive Officer of Neurolutions, Inc. He is an experienced nanotechnologist searching for challenging opportunities in biotechnology and medical device entre- and intrapreneurship. Previously he co-founded Neural Analytics and is also the CEO of Nile AI, Inc.

Dr. Petrossian earned his MBA from the UCLA Anderson School of Management in 2014 and earned his Ph.D. & MS in Biomolecular Nanotechnology & Solid-State Device Physics as an NSF IGERT fellow at Arizona State University in 2007. He also holds a double B.S. in Electrical Engineering & Biomedical Engineering from California State University, Long Beach.